1.888.666.2560
faster hemostasis easier hemostasis effective hemostasis obtain and maintain hemostasis

SyvekExcel® – Fast, Easy, Effective Hemostasis For Vascular Catheterization

SyvekExcel utilizes poly-N-acetyl glucosamine fibers derived from microalgae to assist in obtaining and maintaining hemostasis.

  • Proven results in ACTs up to 3001
  • No foreign materials remain at puncture site2
  • Reduced time to ambulation3
More
syvek excel

Used on More Than 3 Million Patients*

utilized in hospitals

Utilized in 1000+ hospitals nationwide following radial and femoral catheterization.

SyvekNT® Can Reduce Time to Ambulation to 1 Hour

diagnostic patient

One hour bedrest protocol using SyvekNT proved safe and effective in diagnostic patients.4 More

SyvekExcel® is Effective for Anticoagulated Patients

  • Heparin1
  • Angiomax®(bivalirudin)1,3
  • Plavix®(clopidogrel)1,3
  • GPIIbIIIa-receptor antagonists1,3
  • Aspirin1,3
More

Indications for Use:
SyvekNT® is intended for the promotion of rapid control of bleeding in patients following hemodialysis and in patients on anticoagulation therapy. SyvekNT is intended for use in the local management of bleeding wounds such as vascular access site, percutaneous catheters or tubes and surgical debridement. SyvekExcel® is intended for use following femoral vascular catheterization procedures to assist in obtaining and maintaining hemostasis.

Safety Information:
PRECAUTIONS: There are no known contraindications to the use of SyvekNT®. Longer compression may be necessary for hypertensive or obese patients. There are no known contraindications to the use of SyvekExcel®. Longer compression may be necessary for hypertensive or obese patients.
Not made with Natural Rubber Latex
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner.

Manufactured by Marine Polymer Technologies, Inc., Danvers, MA 01923. For instructions for use or additional product information, please contact us.

  • 8,992,453
  • 8,859,528
  • 8,835,408
  • 8,834,516
  • 8,481,512
  • 8,152,750
  • 7,931,637
  • 7,115,588
  • 7,041,657
  1. Ghitis A, Cusnir H, Salajka H, et al. Cardiovasc Revasc Med. 2008; 9(2):128.
  2. Hirsch JA, Reddy SA, Capasso WE,et al. Tech Vasc Interv Radiol. 2003;6:92-95.
  3. Mego D, Thomas M, Stewart J, et al. J Invas Cardiol. 2010; 22:35-39
  4. Palmer B, Gantt D, Lawrence M, et al. Am J Cardiol. 2004; 93:96-97

Angiomax®(bivalirudin) is a registered trademark of The Medicines Company
Plavix®(clopidogrel) is a registered trademark of Sanofi-Aventis

* Data on file, based on total US sales